WO2020070236A1
|
|
(+)-alpha-dihydrotetrabenazine dosage regimen for treating movement disorders
|
US2019111035A1
|
|
Pharmaceutical compositions
|
GB201810109D0
|
|
Pharmaceutical compositions
|
GB201808464D0
|
|
Pharmaceutical compounds for use in treating huntington's disease
|
AU2018241940A1
|
|
Dihydrotetrabenazine for use in the treatment a movement disorder
|
EP3606529A1
|
|
(+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder
|
GB201706816D0
|
|
Pharmaceutical compositions
|
GB201705301D0
|
|
Pharmaceutical compositions
|
GB201705305D0
|
|
Pharmaceutical compositions
|
GB201705304D0
|
|
Pharmaceutical compositions
|
GB201705303D0
|
|
Pharmaceutical compositions
|
GB201705302D0
|
|
Pharmaceutical compositions
|
GB201705306D0
|
|
Pharmaceutical compositions
|
GB201219234D0
|
|
Pharmaceutical compositions
|